MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 164 filers reported holding MIRATI THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.50 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,327,000 | +87.2% | 34,670 | +129.4% | 0.00% | +100.0% |
| Q1 2022 | $1,243,000 | -63.9% | 15,115 | -35.5% | 0.00% | -50.0% |
| Q4 2021 | $3,442,000 | -40.0% | 23,427 | -27.7% | 0.00% | -50.0% |
| Q3 2021 | $5,735,000 | +50.0% | 32,421 | +36.9% | 0.00% | +33.3% |
| Q2 2021 | $3,824,000 | -5.1% | 23,674 | +0.6% | 0.00% | -25.0% |
| Q1 2021 | $4,031,000 | -27.3% | 23,531 | -6.8% | 0.00% | -20.0% |
| Q4 2020 | $5,544,000 | +48.8% | 25,244 | +12.5% | 0.01% | +25.0% |
| Q3 2020 | $3,725,000 | +46.3% | 22,430 | +0.6% | 0.00% | +33.3% |
| Q2 2020 | $2,547,000 | +218.8% | 22,307 | +114.8% | 0.00% | +200.0% |
| Q1 2020 | $799,000 | -81.6% | 10,386 | -69.2% | 0.00% | -75.0% |
| Q4 2019 | $4,343,000 | +523.1% | 33,707 | +285.6% | 0.00% | +300.0% |
| Q3 2019 | $697,000 | -21.9% | 8,741 | +0.9% | 0.00% | 0.0% |
| Q2 2019 | $892,000 | -65.6% | 8,663 | -75.5% | 0.00% | -66.7% |
| Q1 2019 | $2,592,000 | – | 35,364 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 1,000,000 | $31,470,000 | 8.67% |
| Baker Brothers Advisors | 2,805,074 | $88,276,000 | 0.77% |
| Broadfin Capital, LLC | 359,661 | $11,319,000 | 0.61% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 397,660 | $12,514,000 | 0.42% |
| Boulegeris Investments, Inc. | 17,415 | $548,000 | 0.39% |
| SPHERA FUNDS MANAGEMENT LTD. | 95,000 | $2,990,000 | 0.29% |
| Rhenman & Partners Asset Management AB | 50,000 | $1,574,000 | 0.19% |
| Integre Asset Management, LLC | 23,996 | $755,000 | 0.16% |
| Orbimed Advisors | 680,500 | $21,415,000 | 0.16% |
| EAM Investors, LLC | 38,754 | $1,220,000 | 0.14% |